Abstract

The clinical benefits of trastuzumab for treating women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer are unquestioned.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call